| Biotechnology Industry | Healthcare Sector | - CEO | TWSE Exchange | TW0003218004 ISIN |
| Taiwan Country | - Employees | 26 Mar 2026 Last Dividend | 25 Aug 2023 Last Split | - IPO Date |
Universal Vision Biotechnology Co., Ltd., founded in 1992 and headquartered in Taipei, Taiwan, positions itself as a leading provider of eye care solutions across Taiwan and China. The company operates a comprehensive network of eye care clinics dedicated to offering a wide spectrum of treatments and services for various eye conditions. These include but are not limited to myopia, hyperopia, astigmatism, presbyopia, cataracts, dry eyes, retinal detachment, macular degeneration, strabismus, and amblyopia. Beyond clinical services, Universal Vision Biotechnology also delves into the retail aspect by offering vision products and engages in providing hospital management and technical consultancy services, along with the sales and leasing of medical devices, underscoring its diverse approach in the eye care industry.